Simmons R L, Thompson E J, Kjellstrand C M, Yunis E J, Condie R M, Mauer S M, Buselmeier T J, Najarian J S
Lancet. 1976 Feb 14;1(7955):321-4. doi: 10.1016/s0140-6736(76)90082-9.
101 first transplants were done in patients with end-stage renal disease using kidneys from parents or offspring. All patients were followed up for at least two years, and the absolute two-year patient-survival rate was 88% and the two-year functional-kidney rate was 79%. Actuarial statistics at four years were 82% for survival and 67% for function in the parent-to-child group. In the child-to-parent group absolute patient survival was 83% and transplant function was 79% at two years; these results were unchanged at four years. Thus, transplants from parents to children or from children to parents are much the same despite differences in age. There is some advantage in parent-to-child transplants from being female but no advantage in being diabetic, receiving higher or lower doses of antilymphocyte globulin, or sharing more than two HLA antigens with the donor. Mismatched sibling transplants survived approximately as well as did grafts from parents to children and children to parents. These results, taken in concert with the poor results of cadaver transplantation, the relative safety of donation, the high personal motivation to donate in these groups, and the personal satisfaction derived by the donor, strongly support the policy of informing potential recipients of the benefits of parental or offspring kidney donation.
对101例终末期肾病患者进行了首次移植,供肾来自父母或子女。所有患者均接受了至少两年的随访,两年的绝对患者生存率为88%,两年的移植肾功能正常率为79%。亲子组四年的精算统计显示,生存率为82%,肾功能正常率为67%。在子亲组中,两年时绝对患者生存率为83%,移植肾功能正常率为79%;四年时这些结果未变。因此,尽管年龄存在差异,但父母向子女或子女向父母的移植情况大致相同。亲子移植中女性供肾有一定优势,但供者患糖尿病、接受高低剂量抗淋巴细胞球蛋白治疗或与供者共享超过两个HLA抗原并无优势。配型不合的同胞移植的存活情况与父母向子女及子女向父母的移植情况大致相同。这些结果,与尸体肾移植的不良结果、供肾的相对安全性、这些人群中强烈的供肾个人意愿以及供者获得的个人满足感相结合,有力地支持了向潜在受者告知亲属供肾益处的政策。